Regulation of fibronectin gene expression in cardiac fibroblasts by scleraxis

• Published in: Cell and tissue research 2016-11, Vol.366 (2), p.381-391
• Main Authors: Bagchi, Rushita A., Lin, Justin, Wang, Ryan, Czubryt, Michael P.
• Format: Article
• Language: English
• Subjects: Animals; Base Sequence; Basic Helix-Loop-Helix Transcription Factors - metabolism; Biomedical and Life Sciences; Biomedicine; Chromatin; E-Box Elements - genetics; Fibroblasts; Fibroblasts - metabolism; Fibronectins; Fibronectins - genetics; Fibronectins - metabolism; Gene expression; Gene Expression Regulation; Genes; Glycoproteins; Heart; Human Genetics; Male; Mice; Mice, Knockout; Models, Biological; Molecular Medicine; Myocardium - cytology; Myofibroblasts - metabolism; NIH 3T3 Cells; Promoter Regions, Genetic; Proteomics; Rats, Sprague-Dawley; Regular Article; Signal transduction; Transcriptional Activation - genetics; Transforming Growth Factor beta - metabolism; Transforming growth factors
• ISSN: 0302-766X; 1432-0878
• DOI: 10.1007/s00441-016-2439-1

The glycoprotein fibronectin is a key component of the extracellular matrix. By interacting with numerous matrix and cell surface proteins, fibronectin plays important roles in cell adhesion, migration and intracellular signaling. Up-regulation of fibronectin occurs in tissue fibrosis, and previous studies have identified the pro-fibrotic factor TGFβ as an inducer of fibronectin expression, although the mechanism responsible remains unknown. We have previously shown that a key downstream effector of TGFβ signaling in cardiac fibroblasts is the transcription factor scleraxis, which in turn regulates the expression of a wide variety of extracellular matrix genes. We noted that fibronectin expression tracked closely with scleraxis expression, but it was unclear whether scleraxis directly regulated the fibronectin gene. Here, we report that scleraxis acts via two E-box binding sites in the proximal human fibronectin promoter to govern fibronectin expression, with the second E-box being both sufficient and necessary for scleraxis-mediated fibronectin expression to occur. A combination of electrophoretic mobility shift and chromatin immunoprecipitation assays indicated that scleraxis interacted to a greater degree with the second E-box. Over-expression or knockdown of scleraxis resulted in increased or decreased fibronectin expression, respectively, and scleraxis null mice presented with dramatically decreased immunolabeling for fibronectin in cardiac tissue sections compared to wild-type controls. Furthermore, scleraxis was required for TGFβ-induced fibronectin expression: TGFβ lost its ability to induce fibronectin expression following scleraxis knockdown. Together, these results demonstrate a novel and required role for scleraxis in the regulation of cardiac fibroblast fibronectin gene expression basally or in response to TGFβ.